These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1005920)

  • 1. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium.
    Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the combined and separate administration of doxorubicin and coenzyme Q10 on mouse cardiac enzymes.
    Choe JY; Combs AB; Saji S; Folkers K
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):595-8. PubMed ID: 451343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats.
    Combs AB; Kishi T; Porter TH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):333-9. PubMed ID: 1257616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
    Kishi H; Kishi T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):533-40. PubMed ID: 1197930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):721-7. PubMed ID: 785564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus.
    Kishi T; Kishi H; Watanabe T; Folkers K
    J Med; 1976; 7(3-4):307-21. PubMed ID: 1070515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetics in clinical medicine. IX. Gingival and leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease.
    Hansen IL; Iwamoto Y; Kishi T; Folkers K; Thompson LE
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):729-38. PubMed ID: 959667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes.
    Kishi T; Folkers K
    Cancer Treat Rep; 1976 Mar; 60(3):223-4?U9ENG. PubMed ID: 1260779
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction by coenzyme Q10 of the acute toxicity of adriamycin in mice.
    Combs AB; Choe JY; Truong DH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):565-8. PubMed ID: 928953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of experimental radiation pancarditis. II. Correlation between ultrastructural changes of the myocardial mitochondria and succinic dehydrogenase activity in rabbit heart receiving a single dose of X-ray irradiation.
    Maeda S
    Acta Pathol Jpn; 1982 Mar; 32(2):199-218. PubMed ID: 7090813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium.
    Kishi T; Watanabe T; Folkers K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4653-6. PubMed ID: 1070015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
    Cortes EP; Gupta M; Chou C; Amin VC; Folkers K
    Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.
    Yamagami T; Shibata N; Folkers K
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):273-88. PubMed ID: 1153873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible prevention from the progression of cardiotoxicity in adriamycin-treated rabbits by coenzyme Q10.
    Usui T; Ishikura H; Izumi Y; Konishi H; Dohmae N; Sawada H; Uchino H; Matsuda H; Konishi T
    Toxicol Lett; 1982 Jun; 12(1):75-82. PubMed ID: 7112605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the inhibition produced by adriamycin against specific enzymes in the rat heart].
    Fabregat I; Satrústegui J; Machado A
    Rev Esp Oncol; 1982; 29(4):633-40. PubMed ID: 6100465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Succinate dehydrogenase activity of isolated myocardial mitochondria during chronic insufficiency].
    Kleĭmenova NN; Kolesova OE; Chechulin IuS
    Biull Eksp Biol Med; 1976 Jan; 81(1):37-40. PubMed ID: 1247675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10.
    Folkers K; Drzewoski J; Richardson PC; Ellis J; Shizukuishi S; Baker L
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):129-40. PubMed ID: 7255868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of coenzyme Q 10 in a succinate-CoQ 10 -Enzyme in the dystrophic rabbit on an antioxidant deficient diet.
    Littarru GP; Jones D; Scholler J; Folkers K
    Int J Vitam Nutr Res; 1972; 42(1):127-38. PubMed ID: 5019177
    [No Abstract]   [Full Text] [Related]  

  • 20. Deficiency of coenzyme Q10 in the rabbit.
    Boler JB; Farley TM; Scholler J; Folkers K
    Int Z Vitaminforsch; 1969; 39(3):281-8. PubMed ID: 5374962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.